230 results
8-K
EX-10.1
AVGR
Avinger Inc
7 Mar 24
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
6:30am
be responsible for all costs and expenses required to obtain any additional approvals or consents from the FDA as a result of Party A’s transfer … with the Initial Term, the “Term”). Accordingly, Party B shall be responsible for extending its current business term which is to expire on November 4th
8-K
EX-10.5
6bir or6s2h8
7 Mar 24
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
6:30am
8-K
EX-10.2
79na0ros4 tywdtx6
7 Mar 24
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
6:30am
8-K
EX-10.3
2z6fsp
7 Mar 24
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
6:30am
8-K
EX-10.6
sz8z04n
7 Mar 24
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
6:30am
8-K
EX-10.7
xatu1 jo4u
7 Mar 24
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
6:30am
424B5
1qtkpdww6
22 Sep 23
Prospectus supplement for primary offering
6:03am
424B5
os81t8
21 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
pjhs3
20 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
pdvxakdxds0yy 28pd
18 Sep 23
Prospectus supplement for primary offering
4:53pm
8-K
EX-10.1
5wadv498l9mzwj
4 Aug 23
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
9:10am